Overview Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD) Status: Completed Trial end date: 2010-01-01 Target enrollment: Participant gender: Summary Oral administration of Alequel, a mixture of proteins derived from the patient's bowel will be tested in patients with inflammatory bowel disease. Phase: Phase 1/Phase 2 Details Lead Sponsor: Hadassah Medical Organization